Department of Psychiatry
University of Oxford
Oxford, United Kingdom
This program has been made available online.
Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients
Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)
Slides from a presentation that educates clinicians on advances in the treatment of tardive dyskinesia (TD)
In Neuroscience Research Review (GME Research Review), Dr Gupta provides commentary on the latest research relevant to clinical practice for opioid use disorder, emotional exhaustion & burnout, PTSD among veterans and familiar risk of depression.